Back to results
CompletedPhase 4

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

NCT04113109

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Vanderbilt University Medical Center

Nashville, Tennessee, United States

View on ClinicalTrials.gov
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2 — TrialFind